These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20052788)

  • 1. Correction: glucose control and cardiovascular disease in type 2 diabetes.
    Ann Intern Med; 2010 Jan; 152(1):67. PubMed ID: 20052788
    [No Abstract]   [Full Text] [Related]  

  • 2. Concerns about meta-analysis of glucose control and cardiovascular disease in type 2 diabetes.
    Yudkin JS; Richter B
    Ann Intern Med; 2010 Jan; 152(1):63; author reply 63-4. PubMed ID: 20048277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intensive blood glucose lowering to reduce cardiovascular risk: pro].
    Martin S
    Dtsch Med Wochenschr; 2009 May; 134(20):1060. PubMed ID: 19421929
    [No Abstract]   [Full Text] [Related]  

  • 5. Does intensive glycemic control improve cardiovascular outcomes?
    Pendergrass M
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intensive blood glucose lowering to reduce cardiovascular risk: contra].
    Marx N
    Dtsch Med Wochenschr; 2009 May; 134(20):1061. PubMed ID: 19421930
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardioprotection by acarbose--contra].
    Kaiser T; Sawicki PT
    Dtsch Med Wochenschr; 2004 May; 129(20):1156. PubMed ID: 15143460
    [No Abstract]   [Full Text] [Related]  

  • 8. Do not forget that type 2 diabetes does not only expose to cardiovascular complications.
    Halimi S
    Diabetes Metab; 2014 Jun; 40(3):167-8. PubMed ID: 24751987
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
    Schatz H
    Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is hypoglycemia dangerous in type 2 diabetes?].
    Grimaldi A
    Rev Prat; 2015 Sep; 65(7):903-6. PubMed ID: 26619722
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tight glycemic control in the management of diabetic patients: what has changed since the '90s in the clinical approach?].
    Fiorentino TV; Sesti G
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):13S-20S. PubMed ID: 25623546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis.
    Zhang CY; Sun AJ; Zhang SN; Wu CN; Fu MQ; Xia G; Wang KQ; Zou YZ; Ge JB
    Ann Med; 2010 May; 42(4):305-15. PubMed ID: 20429797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieve better glucose control for your hospitalized patients.
    Woolever DR
    J Fam Pract; 2008 Dec; 57(12):782-8. PubMed ID: 19080760
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glycemic control and cardiovascular diseases in type 2 diabetes].
    Madsbad S
    Ugeskr Laeger; 2008 Nov; 170(45):3634. PubMed ID: 18986612
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypoglycemic potential of current and emerging pharmacotherapies in type 2 diabetes mellitus.
    Brunton SA
    Postgrad Med; 2012 Jul; 124(4):74-83. PubMed ID: 22913896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality of healthcare in type 2 diabetes mellitus in Spain].
    Soriguer F; Ruiz de Adana MS
    Med Clin (Barc); 2012 May; 138(12):522-4. PubMed ID: 22118976
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular Safety Trials of Antidiabetic Therapies to Treat Type 2 Diabetes: Perhaps Asking the Wrong Question?
    Psaty BM; Fleming TR
    Am J Hypertens; 2019 Sep; 32(10):927-929. PubMed ID: 31175821
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy and clinical trials: glycaemic control and cardiovascular disease.
    Edavalath M; Rees A
    Curr Opin Lipidol; 2009 Dec; 20(6):530-1. PubMed ID: 19935205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.